Login / Signup

Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.

Schjesvold FredrikSara BringhenPaul Gerard RichardsonAurore PerrotXavier LeleuPhillipe MoreauMeletios- Athanasios DimopoulosCyrille HulinChristina TekleMeredith C FosterElizabeth M PooleHelgi van de VeldeThierry Facon
Published in: American journal of hematology (2021)
Keyphrases
  • multiple myeloma
  • low dose
  • high dose
  • acute myeloid leukemia
  • acute lymphoblastic leukemia
  • diffuse large b cell lymphoma
  • hodgkin lymphoma
  • study protocol
  • randomized controlled trial